PositiveNaija Public Alert 36: The National Agency for Food and Drugs Administration and Control (NAFDAC) is alerting the public on the sale of an unauthorized and unregistered brand of Daratumumab formulation in Nigeria.
An internal investigation conducted by Johnson & Johnson revealed that there are two different packaging designs for their Daratumumab product. One design is intended for the Indian market, while the other is meant for the Arab market.
Continue reading PositiveNaija Public Alert 36: NAFDAC Notifies on the Presence of an Unauthorized/ Unregistered Darzalex (Daratumumab) 1800mg/15ml vial SC Injection in Nigeria